Pro-Dex, Inc. (NASDAQ:PDEX) Director Sells $50,000.00 in Stock

Pro-Dex, Inc. (NASDAQ:PDEX) Director Raymond E. Cabillot sold 1,000 shares of Pro-Dex stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $50.00, for a total transaction of $50,000.00. Following the transaction, the director now directly owns 299,695 shares of the company’s stock, valued at $14,984,750. The trade was a 0.33 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Pro-Dex Stock Down 0.3 %

NASDAQ PDEX opened at $48.92 on Monday. The company has a quick ratio of 1.44, a current ratio of 2.58 and a debt-to-equity ratio of 0.33. The company has a fifty day moving average of $39.78 and a two-hundred day moving average of $39.23. The firm has a market capitalization of $159.53 million, a price-to-earnings ratio of 24.34 and a beta of 0.68. Pro-Dex, Inc. has a 52 week low of $16.84 and a 52 week high of $59.60.

Pro-Dex (NASDAQ:PDEX) last issued its earnings results on Thursday, January 30th. The medical instruments supplier reported $0.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.38 by $0.23. Pro-Dex had a net margin of 11.06% and a return on equity of 21.68%. On average, analysts predict that Pro-Dex, Inc. will post 2 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Separately, StockNews.com lowered shares of Pro-Dex from a “buy” rating to a “hold” rating in a research note on Wednesday, March 12th.

Institutional Trading of Pro-Dex

A number of large investors have recently made changes to their positions in the stock. OMERS ADMINISTRATION Corp purchased a new stake in shares of Pro-Dex during the fourth quarter valued at $313,000. Millennium Management LLC purchased a new stake in shares of Pro-Dex during the fourth quarter valued at $260,000. 683 Capital Management LLC purchased a new stake in shares of Pro-Dex during the fourth quarter valued at $739,000. Northern Trust Corp boosted its stake in shares of Pro-Dex by 14.1% during the fourth quarter. Northern Trust Corp now owns 35,754 shares of the medical instruments supplier’s stock valued at $1,672,000 after purchasing an additional 4,426 shares during the period. Finally, Marshall Wace LLP purchased a new stake in shares of Pro-Dex during the fourth quarter valued at $433,000. 15.28% of the stock is owned by hedge funds and other institutional investors.

About Pro-Dex

Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.